GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · Real-Time Price · USD
0.317
-0.003 (-1.00%)
Nov 22, 2024, 4:00 PM EST - Market closed
GlycoMimetics Market Cap
GlycoMimetics has a market cap or net worth of $20.43 million as of November 22, 2024. Its market cap has decreased by -76.13% in one year.
Market Cap
20.43M
Enterprise Value
6.30M
1-Year Change
-76.13%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since January 10, 2014, GlycoMimetics's market cap has decreased from $146.90M to $20.43M, a decrease of -86.09%. That is a compound annual growth rate of -16.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 24.40M | -83.95% |
| Dec 29, 2023 | 152.00M | -4.28% |
| Dec 30, 2022 | 158.80M | 113.15% |
| Dec 31, 2021 | 74.50M | -58.57% |
| Dec 31, 2020 | 179.80M | -21.62% |
| Dec 31, 2019 | 229.40M | -43.84% |
| Dec 31, 2018 | 408.50M | -29.14% |
| Dec 29, 2017 | 576.50M | 309.74% |
| Dec 30, 2016 | 140.70M | 29.20% |
| Dec 31, 2015 | 108.90M | -19.93% |
| Dec 31, 2014 | 136.00M | -7.42% |
| Jan 10, 2014 | 146.90M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroOne Medical Technologies | 20.98M |
| AEON Biopharma | 20.95M |
| BioXcel Therapeutics | 20.74M |
| ProMIS Neurosciences | 20.72M |
| Kairos Pharma | 20.55M |
| NeuroBo Pharmaceuticals | 20.42M |
| American Shared Hospital Services | 20.16M |
| Spruce Biosciences | 19.96M |